You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Immunotherapy

Citations 61-70 of 81 total displayed.

Past content (since Jan 1998):

The Cutting Edge
Treatment of Stage IA Cutaneous T-Cell Lymphoma With Topical Application of the Immune Response Modifier Imiquimod
Karen Rebecca Suchin; Jacqueline M. Junkins-Hopkins; Alain H. Rook; Hospital of the University of Pennsylvania, Philadelphia
Arch Dermatol 2002; 138: 1137-1139. [Extract] [Full text] [PDF]  

Studies
Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell Carcinoma: Comparison of Dosing Regimens
Stephen Shumack; June Robinson; Steven Kossard; Loren Golitz; Hubert Greenway; Arnold Schroeter; Kara Andres; Mark Amies; Mary Owens
Arch Dermatol 2002; 138: 1165-1171. [Abstract] [Full text] [PDF]  

The Cutting Edge
Infantile Hemangioma: Clinical Resolution With 5% Imiquimod Cream
Maria I. Martinez; Ignacio Sanchez-Carpintero; Paula E. North; Martin C. Mihm Jr
Arch Dermatol 2002; 138: 881-884. [Extract] [Full text] [PDF]  

Observations
Hypopigmentation Associated With an Adenovirus-Mediated gp100/MART-1–Transduced Dendritic Cell Vaccine for Metastatic Melanoma
Hensin Tsao; Peri Millman; Gerald P. Linette; F. Stephen Hodi; Arthur J. Sober; Mark A. Goldberg; Frank G. Haluska
Arch Dermatol 2002; 138: 799-802. [Abstract] [Full text] [PDF]  

Correspondence
Imiquimod and Genital Herpes
Herbert B. Slade; Timothy Schacker; Marcus Conant; Christopher Thoming; Jeffrey Gilbert
Arch Dermatol 2002; 138: 534-535. [Extract] [Full text] [PDF]  

Observations
Tacrolimus Ointment in the Treatment of Chronic Cutaneous Graft-vs-Host Disease: A Case Series of 18 Patients
Caroline J. Choi; Paul Nghiem
Arch Dermatol 2001; 137: 1202-1206. [Abstract] [Full text] [PDF]  

The Cutting Edge
Topical Imiquimod for Acyclovir-Unresponsive Herpes Simplex Virus 2 Infection
Jeffrey Gilbert; Molly M. Drehs; Jeffrey M. Weinberg
Arch Dermatol 2001; 137: 1015-1017. [Extract] [Full text] [PDF]  

Observations
Predictive Model for Immunotherapy of Alopecia Areata With Diphencyprone
Marni C. Wiseman; Jerry Shapiro; Nina MacDonald; Harvey Lui
Arch Dermatol 2001; 137: 1063-1068. [Abstract] [Full text] [PDF]  

The Cutting Edge
Topical Imiquimod to Treat Intraepidermal Carcinoma
Ulrich R. Hengge; Roxana Stark
Arch Dermatol 2001; 137: 709-711. [Extract] [Full text] [PDF]  

Observations
Significant Absorption of Topical Tacrolimus in 3 Patients With Netherton Syndrome
Angel Allen; Elaine Siegfried; Robert Silverman; Mary L. Williams; Peter M. Elias; Sarolta K. Szabo; Neil J. Korman
Arch Dermatol 2001; 137: 747-750. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Immunotherapy
 collections from JAMA & Archives Journals.
 •Related collections:
  •Dermatologic Procedures
  •Dermatologic Laser Surgery
  •Dermatologic Surgery
  •Immunotherapy
  •Phototherapy
  •Dermatologic Procedures, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.